AU2005226901B2 - Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury - Google Patents
Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury Download PDFInfo
- Publication number
- AU2005226901B2 AU2005226901B2 AU2005226901A AU2005226901A AU2005226901B2 AU 2005226901 B2 AU2005226901 B2 AU 2005226901B2 AU 2005226901 A AU2005226901 A AU 2005226901A AU 2005226901 A AU2005226901 A AU 2005226901A AU 2005226901 B2 AU2005226901 B2 AU 2005226901B2
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- phenyl
- formula
- group
- benzoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04007177A EP1579859B1 (en) | 2004-03-25 | 2004-03-25 | Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury |
| EP04007177.1 | 2004-03-25 | ||
| PCT/EP2005/002822 WO2005092315A1 (en) | 2004-03-25 | 2005-03-17 | Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005226901A1 AU2005226901A1 (en) | 2005-10-06 |
| AU2005226901B2 true AU2005226901B2 (en) | 2011-06-02 |
Family
ID=34854609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005226901A Ceased AU2005226901B2 (en) | 2004-03-25 | 2005-03-17 | Use of N-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury |
Country Status (23)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2066335A4 (en) * | 2006-09-26 | 2010-01-20 | Univ Case Western Reserve | ZYTOKINSIGNALISIERUNG |
| EP2308484A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| CN103172547B (zh) * | 2011-12-20 | 2016-10-12 | 天津市国际生物医药联合研究院 | 磺酰胺衍生物的制备及其应用 |
| CN103159674A (zh) * | 2013-04-03 | 2013-06-19 | 苏州安诺生物医药技术有限公司 | 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途 |
| KR20220064039A (ko) | 2020-11-11 | 2022-05-18 | 정성삼 | 척수 손상 예방 또는 치료용 조성물 |
| KR102320780B1 (ko) | 2021-01-29 | 2021-11-02 | 정성삼 | 척추 통증 완화 및 척추 유연성 개선을 위한 조성물 및 이의 제조방법 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010016195A1 (en) * | 1999-02-24 | 2001-08-23 | Tobinick Edward L. | Cytokine antagonists for the treatment of localized disorders |
| WO2002062330A2 (en) * | 2001-02-02 | 2002-08-15 | Dompé S.p.A. | Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| EP1123276B1 (en) * | 1998-10-23 | 2003-01-08 | Dompe' S.P.A. | N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1318466B1 (it) * | 2000-04-14 | 2003-08-25 | Dompe Spa | Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria. |
-
2004
- 2004-03-25 DE DE602004003673T patent/DE602004003673T2/de not_active Expired - Lifetime
- 2004-03-25 AT AT04007177T patent/ATE347883T1/de active
- 2004-03-25 ES ES04007177T patent/ES2279248T3/es not_active Expired - Lifetime
- 2004-03-25 SI SI200430194T patent/SI1579859T1/sl unknown
- 2004-03-25 PT PT04007177T patent/PT1579859E/pt unknown
- 2004-03-25 PL PL04007177T patent/PL1579859T3/pl unknown
- 2004-03-25 EP EP04007177A patent/EP1579859B1/en not_active Expired - Lifetime
- 2004-03-25 DK DK04007177T patent/DK1579859T3/da active
-
2005
- 2005-03-17 KR KR1020127023407A patent/KR101327150B1/ko not_active Expired - Fee Related
- 2005-03-17 RU RU2006137575/15A patent/RU2396075C2/ru not_active IP Right Cessation
- 2005-03-17 CA CA2555162A patent/CA2555162C/en not_active Expired - Fee Related
- 2005-03-17 WO PCT/EP2005/002822 patent/WO2005092315A1/en not_active Ceased
- 2005-03-17 NZ NZ548917A patent/NZ548917A/en not_active IP Right Cessation
- 2005-03-17 CN CN2012104176511A patent/CN103054842A/zh active Pending
- 2005-03-17 BR BRPI0509167-5A patent/BRPI0509167A/pt active Search and Examination
- 2005-03-17 CN CNA2005800095602A patent/CN1933825A/zh active Pending
- 2005-03-17 US US10/588,454 patent/US20090030083A1/en not_active Abandoned
- 2005-03-17 AU AU2005226901A patent/AU2005226901B2/en not_active Ceased
- 2005-03-17 KR KR1020067018031A patent/KR101312235B1/ko not_active Expired - Fee Related
- 2005-03-17 MX MXPA06009085A patent/MXPA06009085A/es active IP Right Grant
- 2005-03-17 JP JP2007504310A patent/JP4988550B2/ja not_active Expired - Fee Related
-
2006
- 2006-07-31 IL IL177169A patent/IL177169A/en not_active IP Right Cessation
- 2006-10-12 ZA ZA2006/08517A patent/ZA200608517B/en unknown
- 2006-10-23 NO NO20064793A patent/NO20064793L/no not_active Application Discontinuation
-
2007
- 2007-02-22 CY CY20071100248T patent/CY1107562T1/el unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1123276B1 (en) * | 1998-10-23 | 2003-01-08 | Dompe' S.P.A. | N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| US20010016195A1 (en) * | 1999-02-24 | 2001-08-23 | Tobinick Edward L. | Cytokine antagonists for the treatment of localized disorders |
| WO2002062330A2 (en) * | 2001-02-02 | 2002-08-15 | Dompé S.p.A. | Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0509167A (pt) | 2007-09-11 |
| IL177169A (en) | 2010-12-30 |
| JP2007530478A (ja) | 2007-11-01 |
| EP1579859B1 (en) | 2006-12-13 |
| DE602004003673T2 (de) | 2007-10-04 |
| DK1579859T3 (da) | 2007-04-10 |
| EP1579859A1 (en) | 2005-09-28 |
| RU2396075C2 (ru) | 2010-08-10 |
| JP4988550B2 (ja) | 2012-08-01 |
| AU2005226901A1 (en) | 2005-10-06 |
| CA2555162C (en) | 2012-11-27 |
| MXPA06009085A (es) | 2007-04-02 |
| NZ548917A (en) | 2010-06-25 |
| CN1933825A (zh) | 2007-03-21 |
| CY1107562T1 (el) | 2013-03-13 |
| ATE347883T1 (de) | 2007-01-15 |
| ZA200608517B (en) | 2008-04-30 |
| WO2005092315A1 (en) | 2005-10-06 |
| RU2006137575A (ru) | 2008-04-27 |
| KR101327150B1 (ko) | 2013-11-06 |
| CA2555162A1 (en) | 2005-10-06 |
| US20090030083A1 (en) | 2009-01-29 |
| PL1579859T3 (pl) | 2007-06-29 |
| DE602004003673D1 (de) | 2007-01-25 |
| ES2279248T3 (es) | 2007-08-16 |
| CN103054842A (zh) | 2013-04-24 |
| SI1579859T1 (sl) | 2007-04-30 |
| KR20120104445A (ko) | 2012-09-20 |
| PT1579859E (pt) | 2007-03-30 |
| IL177169A0 (en) | 2006-12-10 |
| NO20064793L (no) | 2006-10-23 |
| KR20070018015A (ko) | 2007-02-13 |
| KR101312235B1 (ko) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003535034A (ja) | ジペプチジルペプチダーゼiv阻害剤並びにジペプチジルペプチダーゼiv阻害剤の製造及び使用法 | |
| KR19990044182A (ko) | 말초 활성 통각과민 치료용 아편제 | |
| DE60032335T2 (de) | Verfahren zur wiederherstellung und/oder erhöhung der aufnahmefähigkeit in pseudo phakia | |
| JP2004508404A (ja) | 鎮痛手法 | |
| RU2299731C2 (ru) | Агонисты никотиновых рецепторов для лечения воспалительных заболеваний | |
| US11738040B2 (en) | Composition for treating joint disease and kit containing same | |
| JP6650650B2 (ja) | 神経系疾患治療剤 | |
| JP2003176240A (ja) | ニコチン性アセチルコリン受容体作用薬により関節の潤滑を高める方法 | |
| CA2555162C (en) | Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury | |
| JP6509244B2 (ja) | 水晶体硬化抑制剤 | |
| EP1806136B1 (en) | Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy | |
| Smith et al. | Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process. | |
| HK1184385A (en) | Use of n-(2-aryl-propionyl)-sulfonamides for the preparation of a medicament for the treatment of spinal cord injury | |
| KR100324447B1 (ko) | 아티파메졸을 함유하는 남성 성기능 장애 치료용 약학적 조성물 | |
| US7439270B2 (en) | Drugs for spinal anesthesia | |
| HK1101358A (en) | Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury | |
| JP2003522792A (ja) | 薬剤調製用化合物の用途 | |
| Baine | The Effects of Sex on Spinal Cord Injury Recovery Following Noxious Input | |
| CZ20013048A3 (cs) | Terapeutický prostředek proti bolesti v lýtkových svalech při chůzi | |
| KR20100015014A (ko) | 프레가발린을 포함하는 척수 손상을 예방 및 치료하는약제학적 조성물 | |
| Sorbera | RDP-58 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |